Clinical assessment of Optivate®, a high-purity concentrate of factor VIII with von Willebrand factor, in the management of patients with haemophilia A

Dmoszynska, A., Kuliczkowski, K., Hellmann, A. et al. (10 more authors) (2011) Clinical assessment of Optivate®, a high-purity concentrate of factor VIII with von Willebrand factor, in the management of patients with haemophilia A. Haemophilia, 17 (3). pp. 456-462. ISSN 1351-8216

Abstract

Metadata

Authors/Creators:
  • Dmoszynska, A.
  • Kuliczkowski, K.
  • Hellmann, A.
  • Trelinski, J.
  • Kloczko, J.
  • Baglin, T.
  • Hay, C.
  • O'Shaughnessy, D.
  • Zawilska, K.
  • Makris, M. ORCID logo https://orcid.org/0000-0001-7622-7939
  • Shaikh-Zaidi, R.
  • Gascoigne, E.
  • Dash, C.
Copyright, Publisher and Additional Information: © 2011 Blackwell Publishing Ltd.
Keywords: efficacy; factor VIII; haemophilia A; plasma-derived concentrates; safety
Dates:
  • Published (online): 4 March 2011
  • Published: 26 April 2011
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 10 Jun 2020 09:32
Last Modified: 10 Jun 2020 09:32
Status: Published
Publisher: Wiley
Refereed: Yes
Identification Number: https://doi.org/10.1111/j.1365-2516.2010.02446.x

Share / Export

Statistics